Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

A. Bronden; H. H. Nerild; C. C. Nexoe-Larsen; P. H. Hellmann; M. Baekdal; I. M. Gether; M. P. Gillum; Bolette Hartmann; L. B. Knudsen; L. V. Jacobsen; J. F. Rehfeld; J. J. Holst; T. Vilsboll; D. P. Sonne; F. K. Knop

Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

A. Bronden, H. H. Nerild, C. C. Nexoe-Larsen, P. H. Hellmann, M. Baekdal, I. M. Gether, M. P. Gillum, Bolette Hartmann, L. B. Knudsen, L. V. Jacobsen, J. F. Rehfeld, J. J. Holst, T. Vilsboll, D. P. Sonne, F. K. Knop

Originalsprog	Engelsk
Publikationsdato	sep. 2021
Antal sider	1
Status	Udgivet - sep. 2021

Citationsformater

Bronden, A., Nerild, H. H., Nexoe-Larsen, C. C., Hellmann, P. H., Baekdal, M., Gether, I. M., Gillum, M. P., Hartmann, B., Knudsen, L. B., Jacobsen, L. V., Rehfeld, J. F., Holst, J. J., Vilsboll, T., Sonne, D. P., & Knop, F. K. (2021). Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity. 94-94.

Bronden, A , Nerild, HH, Nexoe-Larsen, CC, Hellmann, PH , Baekdal, M , Gether, IM, Gillum, MP, Hartmann, B, Knudsen, LB, Jacobsen, LV, Rehfeld, JF, Holst, JJ, Vilsboll, T , Sonne, DP & Knop, FK 2021, 'Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity', s. 94-94.

@conference{3ccc52ed48ea480eb40cc59c34a3aeaf,

title = "Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity",

author = "A. Bronden and Nerild, {H. H.} and Nexoe-Larsen, {C. C.} and Hellmann, {P. H.} and M. Baekdal and Gether, {I. M.} and Gillum, {M. P.} and Bolette Hartmann and Knudsen, {L. B.} and Jacobsen, {L. V.} and Rehfeld, {J. F.} and Holst, {J. J.} and T. Vilsboll and Sonne, {D. P.} and Knop, {F. K.}",

year = "2021",

month = sep,

language = "English",

pages = "94--94",

}

TY - ABST

T1 - Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

AU - Bronden, A.

AU - Nerild, H. H.

AU - Nexoe-Larsen, C. C.

AU - Hellmann, P. H.

AU - Baekdal, M.

AU - Gether, I. M.

AU - Gillum, M. P.

AU - Hartmann, Bolette

AU - Knudsen, L. B.

AU - Jacobsen, L. V.

AU - Rehfeld, J. F.

AU - Holst, J. J.

AU - Vilsboll, T.

AU - Sonne, D. P.

AU - Knop, F. K.

PY - 2021/9

Y1 - 2021/9

M3 - Conference abstract for conference

SP - 94

EP - 94

ER -